SECTOR:
Therapeutics
FUND/VEHICLE:
Pivotal Growth Investments, Pivotal US
INVESTMENT DATE:
2012
GEOGRAPHY:
Europe
STATUS CURRENT/FORMER INVESTMENT:
Current
WEBSITE:
Finding faster and smarter ways to discover new and better drugs is what drives Exscientia.
By actively applying AI to precision engineer medicines more rapidly and efficiently, we will enable people to live more healthy and productive lives.
AI is at the heart of everything we do. We’re re-imagining the entire drug discovery process and re-engineering through the thoughtful application AI and machine learning techniques.